Form 4: Vicarious Surgical Director Granted Stock Options

Vicarious Surgical Inc. director Donald F Tang was granted 5,335 stock options with an exercise price of $7.61, vesting on June 27, 2026, or earlier.

Summary

• Donald F Tang, a Director of Vicarious Surgical Inc. (RBOT), was granted 5,335 stock options.
• The options have an exercise price of $7.61 per share.
• The grant date for these options was June 27, 2025.
• The options are set to expire on June 26, 2035.
• All 5,335 shares underlying the option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier.
• Vesting is contingent upon Mr. Tang's continued service through the applicable vesting date.
• Following this transaction, Mr. Tang directly beneficially owns 5,335 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a director is a positive event for corporate governance and aligns management incentives with shareholder interests. It's a routine compensation event, not a major market mover, hence a moderately positive score.

Positives

• The grant of stock options to a director aligns their interests with those of shareholders, incentivizing long-term performance and retention.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

This filing does not provide forward-looking statements or guidance beyond the vesting schedule of the granted options.

Industry Context

This is a routine compensation disclosure for a director, common across publicly traded companies, and does not provide specific industry context or trends.

Stakeholder Impact

• Shareholders: Aligns director's interests with shareholder value creation. Potential for minor dilution if options are exercised in the future.

Next Steps

• Continued service of Donald F Tang through the vesting date.
• Potential exercise of options by Donald F Tang after vesting and before expiration.

Key Dates

Recommendation

This Form 4 filing reports a routine stock option grant to a director, which is a standard compensation practice aimed at aligning interests. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It's a neutral event in terms of immediate investment action, supporting a 'hold' stance for existing investors.

Keywords

Vicarious Surgical, RBOT, Stock Options, Director Compensation, SEC Form 4, Beneficial Ownership, Equity Grant, Donald F Tang